0.6619 USD
-0.02 (-2.39%)
0.6619 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 87% to VTGN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.4. This target is 1017.24% above the current price.
VTGN was analyzed by 11 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about VTGN.
In the previous month the buy percentage consensus was at a similar level.
VTGN was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-17 | William Blair | Downgrade | Outperform -> Market Perform |
| 2025-12-17 | Maxim Group | Downgrade | Buy -> Hold |
| 2025-12-17 | Jefferies | Downgrade | Buy -> Hold |
| 2023-12-07 | Jefferies | Upgrade | Hold -> Buy |
| 2023-11-14 | Stifel | Initiate | Buy |
| 2023-09-05 | Maxim Group | Maintains | Buy -> Buy |
| 2023-08-07 | Maxim Group | Upgrade | Hold -> Buy |
| 2022-07-26 | Maxim Group | Downgrade | Buy -> Hold |
| 2022-07-22 | William Blair | Downgrade | Outperform -> Market Perform |
| 2021-05-20 | Baird | Initiate | Outperform |
| 2021-02-18 | Jefferies | Initiate | Buy |
VISTAGEN THERAPEUTICS INC / VTGN FAQ
What is the price target for VTGN stock?
11 analysts have analysed VTGN and the average price target is 7.4 USD. This implies a price increase of 1017.24% is expected in the next year compared to the current price of 0.6619.
Can you provide the consensus rating for VISTAGEN THERAPEUTICS INC stock?
The consensus rating for VISTAGEN THERAPEUTICS INC (VTGN) is 87.2727 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for VISTAGEN THERAPEUTICS INC stock?
The number of analysts covering VISTAGEN THERAPEUTICS INC (VTGN) is 11.